Accession |
PRJCA013959 |
Title |
SHR1210Clinical study of carrelizumab combined with cetuximab and chemotherapy in the treatment of Ras wild-type colorectal cancer |
Relevance |
Medical |
Data types |
Involves biomarker data
|
Organisms |
Homo sapiens
|
Description |
Contains biomarker data |
Sample scope |
Multiisolate |
Release date |
2022-12-19 |
Grants |
Agency |
program |
Grant ID |
Grant title |
NA
|
NA
|
NA
|
NA
|
|
Submitter |
jiao
liu (jiao.liu.jl119@hengrui.com)
|
Organization |
Jiangsu Hengrui Pharmaceutical Co., Ltd |
Submission date |
2022-12-19 |